M T Lupo-Stanghellini
Overview
Explore the profile of M T Lupo-Stanghellini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farina F, Sannipoli D, Diral E, Mastaglio S, Oltolini C, DellAcqua R, et al.
J Infect
. 2024 Nov;
89(6):106347.
PMID: 39577492
No abstract available.
2.
Farina F, Ferla V, Marktel S, Clerici D, Mastaglio S, Perini T, et al.
Front Oncol
. 2022 Aug;
12:867301.
PMID: 35928865
Life expectancy of multiple myeloma (MM) patients has improved in last years due to the advent of anti-CD38 monoclonal antibodies in combination with immunomodulators and proteasome inhibitors. However, morbidity and...
3.
DeFilipp Z, Duarte R, Snowden J, Majhail N, Greenfield D, Miranda J, et al.
Bone Marrow Transplant
. 2016 Aug;
52(2):173-182.
PMID: 27548466
Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause mortality. Long-term survivors of hematopoietic cell transplantation (HCT)...
4.
Inamoto Y, Shah N, Savani B, Shaw B, Abraham A, Ahmed I, et al.
Bone Marrow Transplant
. 2015 Mar;
50(8):1013-23.
PMID: 25822223
Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group...
5.
Phipps C, Lupo-Stanghellini M, Flowers M
Bone Marrow Transplant
. 2013 Oct;
49(2):315-6.
PMID: 24076547
No abstract available.
6.
Ciceri F, Lupo-Stanghellini M, Korthof E
Bone Marrow Transplant
. 2013 Jan;
48(2):183-5.
PMID: 23292235
Haploidentical SCT (haplo-SCT) has been considered a therapeutic option in patients with acquired severe aplastic anemia (SAA) failing at least one course of immune suppressive therapy with antithymocyte globulin and...